List of Tables
Table 1. Global Patient Derived Xenograft Models Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Patient Derived Xenograft Models Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Patient Derived Xenograft Models Market Competitive Situation by Manufacturers in 2024
Table 4. Global Patient Derived Xenograft Models Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Patient Derived Xenograft Models Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Patient Derived Xenograft Models Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Patient Derived Xenograft Models Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Patient Derived Xenograft Models Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Patient Derived Xenograft Models, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Patient Derived Xenograft Models, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Patient Derived Xenograft Models, Product Type & Application
Table 12. Global Key Manufacturers of Patient Derived Xenograft Models, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Patient Derived Xenograft Models by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patient Derived Xenograft Models as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Patient Derived Xenograft Models Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Patient Derived Xenograft Models Sales by Region (2020-2025) & (K Units)
Table 18. Global Patient Derived Xenograft Models Sales Market Share by Region (2020-2025)
Table 19. Global Patient Derived Xenograft Models Sales by Region (2026-2031) & (K Units)
Table 20. Global Patient Derived Xenograft Models Sales Market Share by Region (2026-2031)
Table 21. Global Patient Derived Xenograft Models Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Patient Derived Xenograft Models Revenue Market Share by Region (2020-2025)
Table 23. Global Patient Derived Xenograft Models Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Patient Derived Xenograft Models Revenue Market Share by Region (2026-2031)
Table 25. North America Patient Derived Xenograft Models Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Patient Derived Xenograft Models Sales by Country (2020-2025) & (K Units)
Table 27. North America Patient Derived Xenograft Models Sales by Country (2026-2031) & (K Units)
Table 28. North America Patient Derived Xenograft Models Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Patient Derived Xenograft Models Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Patient Derived Xenograft Models Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Patient Derived Xenograft Models Sales by Country (2020-2025) & (K Units)
Table 32. Europe Patient Derived Xenograft Models Sales by Country (2026-2031) & (K Units)
Table 33. Europe Patient Derived Xenograft Models Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Patient Derived Xenograft Models Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Patient Derived Xenograft Models Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Patient Derived Xenograft Models Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Patient Derived Xenograft Models Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Patient Derived Xenograft Models Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Patient Derived Xenograft Models Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Patient Derived Xenograft Models Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Patient Derived Xenograft Models Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Patient Derived Xenograft Models Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Patient Derived Xenograft Models Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Patient Derived Xenograft Models Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Patient Derived Xenograft Models Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Patient Derived Xenograft Models Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Patient Derived Xenograft Models Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Patient Derived Xenograft Models Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Patient Derived Xenograft Models Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Patient Derived Xenograft Models Sales (K Units) by Type (2020-2025)
Table 51. Global Patient Derived Xenograft Models Sales (K Units) by Type (2026-2031)
Table 52. Global Patient Derived Xenograft Models Sales Market Share by Type (2020-2025)
Table 53. Global Patient Derived Xenograft Models Sales Market Share by Type (2026-2031)
Table 54. Global Patient Derived Xenograft Models Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Patient Derived Xenograft Models Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Patient Derived Xenograft Models Revenue Market Share by Type (2020-2025)
Table 57. Global Patient Derived Xenograft Models Revenue Market Share by Type (2026-2031)
Table 58. Global Patient Derived Xenograft Models Price (USD/Unit) by Type (2020-2025)
Table 59. Global Patient Derived Xenograft Models Price (USD/Unit) by Type (2026-2031)
Table 60. Global Patient Derived Xenograft Models Sales (K Units) by Application (2020-2025)
Table 61. Global Patient Derived Xenograft Models Sales (K Units) by Application (2026-2031)
Table 62. Global Patient Derived Xenograft Models Sales Market Share by Application (2020-2025)
Table 63. Global Patient Derived Xenograft Models Sales Market Share by Application (2026-2031)
Table 64. Global Patient Derived Xenograft Models Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Patient Derived Xenograft Models Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Patient Derived Xenograft Models Revenue Market Share by Application (2020-2025)
Table 67. Global Patient Derived Xenograft Models Revenue Market Share by Application (2026-2031)
Table 68. Global Patient Derived Xenograft Models Price (USD/Unit) by Application (2020-2025)
Table 69. Global Patient Derived Xenograft Models Price (USD/Unit) by Application (2026-2031)
Table 70. Crown Bioscience Inc. (US) Company Information
Table 71. Crown Bioscience Inc. (US) Description and Business Overview
Table 72. Crown Bioscience Inc. (US) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Crown Bioscience Inc. (US) Patient Derived Xenograft Models Product
Table 74. Crown Bioscience Inc. (US) Recent Developments/Updates
Table 75. WuXi AppTec (China) Company Information
Table 76. WuXi AppTec (China) Description and Business Overview
Table 77. WuXi AppTec (China) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. WuXi AppTec (China) Patient Derived Xenograft Models Product
Table 79. WuXi AppTec (China) Recent Developments/Updates
Table 80. Champions Oncology (US) Company Information
Table 81. Champions Oncology (US) Description and Business Overview
Table 82. Champions Oncology (US) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Champions Oncology (US) Patient Derived Xenograft Models Product
Table 84. Champions Oncology (US) Recent Developments/Updates
Table 85. The Jackson Laboratory (US) Company Information
Table 86. The Jackson Laboratory (US) Description and Business Overview
Table 87. The Jackson Laboratory (US) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. The Jackson Laboratory (US) Patient Derived Xenograft Models Product
Table 89. The Jackson Laboratory (US) Recent Developments/Updates
Table 90. ONCODESIGN (France) Company Information
Table 91. ONCODESIGN (France) Description and Business Overview
Table 92. ONCODESIGN (France) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. ONCODESIGN (France) Patient Derived Xenograft Models Product
Table 94. ONCODESIGN (France) Recent Developments/Updates
Table 95. Charles River Laboratories International (US) Company Information
Table 96. Charles River Laboratories International (US) Description and Business Overview
Table 97. Charles River Laboratories International (US) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Charles River Laboratories International (US) Patient Derived Xenograft Models Product
Table 99. Charles River Laboratories International (US) Recent Developments/Updates
Table 100. EPO Berlin-Buch GmBH (Germany) Company Information
Table 101. EPO Berlin-Buch GmBH (Germany) Description and Business Overview
Table 102. EPO Berlin-Buch GmBH (Germany) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. EPO Berlin-Buch GmBH (Germany) Patient Derived Xenograft Models Product
Table 104. EPO Berlin-Buch GmBH (Germany) Recent Developments/Updates
Table 105. Shanghai LIDE Biotech Co., Ltd (China) Company Information
Table 106. Shanghai LIDE Biotech Co., Ltd (China) Description and Business Overview
Table 107. Shanghai LIDE Biotech Co., Ltd (China) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Shanghai LIDE Biotech Co., Ltd (China) Patient Derived Xenograft Models Product
Table 109. Shanghai LIDE Biotech Co., Ltd (China) Recent Developments/Updates
Table 110. Xentech (France) Company Information
Table 111. Xentech (France) Description and Business Overview
Table 112. Xentech (France) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Xentech (France) Patient Derived Xenograft Models Product
Table 114. Xentech (France) Recent Developments/Updates
Table 115. Horizon Discovery Group PLC (UK) Company Information
Table 116. Horizon Discovery Group PLC (UK) Description and Business Overview
Table 117. Horizon Discovery Group PLC (UK) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Horizon Discovery Group PLC (UK) Patient Derived Xenograft Models Product
Table 119. Horizon Discovery Group PLC (UK) Recent Developments/Updates
Table 120. Urolead (France) Company Information
Table 121. Urolead (France) Description and Business Overview
Table 122. Urolead (France) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Urolead (France) Patient Derived Xenograft Models Product
Table 124. Urolead (France) Recent Developments/Updates
Table 125. Explora BioLabs (US) Company Information
Table 126. Explora BioLabs (US) Description and Business Overview
Table 127. Explora BioLabs (US) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Explora BioLabs (US) Patient Derived Xenograft Models Product
Table 129. Explora BioLabs (US) Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Patient Derived Xenograft Models Distributors List
Table 133. Patient Derived Xenograft Models Customers List
Table 134. Patient Derived Xenograft Models Market Trends
Table 135. Patient Derived Xenograft Models Market Drivers
Table 136. Patient Derived Xenograft Models Market Challenges
Table 137. Patient Derived Xenograft Models Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Patient Derived Xenograft Models
Figure 2. Global Patient Derived Xenograft Models Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Patient Derived Xenograft Models Market Share by Type: 2024 & 2031
Figure 4. Mice Models Product Picture
Figure 5. Rat Models Product Picture
Figure 6. Global Patient Derived Xenograft Models Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Patient Derived Xenograft Models Market Share by Application: 2024 & 2031
Figure 8. Pharmaceutical & Biotechnology Companies
Figure 9. Contract Research Organizations
Figure 10. Academic & Research Institutions
Figure 11. Global Patient Derived Xenograft Models Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Patient Derived Xenograft Models Market Size (2020-2031) & (US$ Million)
Figure 13. Global Patient Derived Xenograft Models Sales (2020-2031) & (K Units)
Figure 14. Global Patient Derived Xenograft Models Average Price (USD/Unit) & (2020-2031)
Figure 15. Patient Derived Xenograft Models Report Years Considered
Figure 16. Patient Derived Xenograft Models Sales Share by Manufacturers in 2024
Figure 17. Global Patient Derived Xenograft Models Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Patient Derived Xenograft Models Players: Market Share by Revenue in Patient Derived Xenograft Models in 2024
Figure 19. Patient Derived Xenograft Models Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Patient Derived Xenograft Models Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Patient Derived Xenograft Models Sales Market Share by Country (2020-2031)
Figure 22. North America Patient Derived Xenograft Models Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Patient Derived Xenograft Models Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Patient Derived Xenograft Models Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Patient Derived Xenograft Models Sales Market Share by Country (2020-2031)
Figure 26. Europe Patient Derived Xenograft Models Revenue Market Share by Country (2020-2031)
Figure 27. Germany Patient Derived Xenograft Models Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Patient Derived Xenograft Models Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Patient Derived Xenograft Models Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Patient Derived Xenograft Models Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Patient Derived Xenograft Models Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Patient Derived Xenograft Models Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Patient Derived Xenograft Models Revenue Market Share by Region (2020-2031)
Figure 34. China Patient Derived Xenograft Models Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Patient Derived Xenograft Models Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Patient Derived Xenograft Models Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Patient Derived Xenograft Models Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Patient Derived Xenograft Models Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Taiwan Patient Derived Xenograft Models Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Patient Derived Xenograft Models Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Patient Derived Xenograft Models Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Patient Derived Xenograft Models Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Patient Derived Xenograft Models Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Patient Derived Xenograft Models Sales Market Share by Country (2020-2031)
Figure 45. Latin America Patient Derived Xenograft Models Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Patient Derived Xenograft Models Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Patient Derived Xenograft Models Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Patient Derived Xenograft Models Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Patient Derived Xenograft Models Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Patient Derived Xenograft Models Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Patient Derived Xenograft Models Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Patient Derived Xenograft Models Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. U.A.E Patient Derived Xenograft Models Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Patient Derived Xenograft Models by Type (2020-2031)
Figure 55. Global Revenue Market Share of Patient Derived Xenograft Models by Type (2020-2031)
Figure 56. Global Patient Derived Xenograft Models Price (USD/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Patient Derived Xenograft Models by Application (2020-2031)
Figure 58. Global Revenue Market Share of Patient Derived Xenograft Models by Application (2020-2031)
Figure 59. Global Patient Derived Xenograft Models Price (USD/Unit) by Application (2020-2031)
Figure 60. Patient Derived Xenograft Models Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
